OnKure Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jan '26 Jan 20, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	40	115	-	-
Enterprise Value	-29	243	-	-
Last Close Price	3.00	8.60	-	-
PB Ratio	0.61	1.11	-	-
P/TBV Ratio	0.61	1.11	-	-
Debt / Equity Ratio	0.01	0.01	0.02	0.06
Quick Ratio	11.26	10.52	4.10	2.08
Current Ratio	11.45	10.73	4.64	2.46
Return on Equity (ROE)	-207.36%	-79.92%	-186.07%	-
Return on Assets (ROA)	-96.53%	-44.43%	-89.24%	-
Return on Invested Capital (ROIC)	-121.86%	-50.10%	-117.58%	-
Return on Capital Employed (ROCE)	-100.10%	-51.30%	-129.80%	-284.70%
Earnings Yield	-156.12%	-45.91%	-	-
FCF Yield	-156.78%	-44.60%	-	-
Buyback Yield / Dilution	0.56%	-1114.54%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q